Preclinical Safety Evaluation of Biopharmaceuticals

Preclinical Safety Evaluation of Biopharmaceuticals
Author :
Publisher : John Wiley & Sons
Total Pages : 1012
Release :
ISBN-10 : 9781118679388
ISBN-13 : 1118679385
Rating : 4/5 (385 Downloads)

Book Synopsis Preclinical Safety Evaluation of Biopharmaceuticals by : Joy A. Cavagnaro

Download or read book Preclinical Safety Evaluation of Biopharmaceuticals written by Joy A. Cavagnaro and published by John Wiley & Sons. This book was released on 2013-03-07 with total page 1012 pages. Available in PDF, EPUB and Kindle. Book excerpt: "The goal is to provide a comprehensive reference book for the preclinicaldiscovery and development scientist whose responsibilities span target identification, lead candidate selection, pharmacokinetics, pharmacology, and toxicology, and for regulatory scientists whose responsibilities include the evaluation of novel therapies." —From the Afterword by Anthony D. Dayan Proper preclinical safety evaluation can improve the predictive value, lessen the time and cost of launching new biopharmaceuticals, and speed potentially lifesaving drugs to market. This guide covers topics ranging from lead candidate selection to establishing proof of concept and toxicity testing to the selection of the first human doses. With chapters contributed by experts in their specific areas, Preclinical Safety Evaluation of Biopharmaceuticals: A Science-Based Approach to Facilitating Clinical Trials: Includes an overview of biopharmaceuticals with information on regulation and methods of production Discusses the principles of ICH S6 and their implementation in the U.S., Europe, and Japan Covers current practices in preclinical development and includes a comparison of safety assessments for small molecules with those for biopharmaceuticals Addresses all aspects of the preclinical evaluation process, including: the selection of relevant species; safety/toxicity endpoints; specific considerations based upon class; and practical considerations in the design, implementation, and analysis of biopharmaceuticals Covers transitioning from preclinical development to clinical trials This is a hands-on, straightforward reference for professionals involved in preclinical drug development, including scientists, toxicologists, project managers, consultants, and regulatory personnel.


Preclinical Safety Evaluation of Biopharmaceuticals Related Books

Preclinical Safety Evaluation of Biopharmaceuticals
Language: en
Pages: 1012
Authors: Joy A. Cavagnaro
Categories: Medical
Type: BOOK - Published: 2013-03-07 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

"The goal is to provide a comprehensive reference book for the preclinicaldiscovery and development scientist whose responsibilities span target identification,
Translational Medicine
Language: en
Pages: 952
Authors: Joy A. Cavagnaro
Categories: Medical
Type: BOOK - Published: 2021-11-26 - Publisher: CRC Press

DOWNLOAD EBOOK

Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals provides scientists responsible for the translation of novel biopharmaceu
The Textbook of Pharmaceutical Medicine
Language: en
Pages: 883
Authors: John P. Griffin
Categories: Medical
Type: BOOK - Published: 2008-04-15 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

New edition of succesful standard reference book for thepharmaceutical industry and pharmaceutical physicians! The Textbook of Pharmaceutical Medicine is the co
Clinical Trials of Drugs and Biopharmaceuticals
Language: en
Pages: 520
Authors: Chi-Jen Lee
Categories: Medical
Type: BOOK - Published: 2005-09-19 - Publisher: CRC Press

DOWNLOAD EBOOK

The pharmaceutical industry is on the verge of an exciting and challenging century. Advances in pharmaceutical sciences have dramatically changed the processes
Advanced Issue Resolution in Safety Pharmacology
Language: en
Pages: 0
Authors: Mary Jeanne Kallman
Categories: Medical
Type: BOOK - Published: 2018-09-07 - Publisher: Academic Press

DOWNLOAD EBOOK

Advanced Issue Resolution in Safety Pharmacology not only discusses unique issues that may emerge during the development of new medicines, but also provides det